CONTACT

+91 80 2808 2808

ContactUs.BBL@biocon.com

Press Releases 2016

Biocon Biologics / News – Posts / Press Releases / Press Releases 2016

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data

Tue, 27-Dec-2016
Posted by: Biocon Biologics

Biocon Features in Asia IP Elite 2016 List

Fri, 09-Dec-2016
Posted by: Biocon Biologics

Biocon’s Novel Diabetes Education Initiative for Medical Practitioners ‘ABIDE’ Awarded by RSSDI

Tue, 29-Nov-2016
Posted by: Biocon Biologics

Biocon Collaborates with Healthcare Professionals for a Public Awareness Campaign on Diabetes Prevention & Management Across India

Fri, 11-Nov-2016
Posted by: Biocon Biologics

Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab

Tue, 08-Nov-2016
Posted by: Biocon Biologics

Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency

Thu, 03-Nov-2016
Posted by: Biocon Biologics

Biocon Ranked Among Global Top Ten Biotech Employers; The only Asian Company to Feature in 2016 Rankings Biocon moves up to No. 9 from No. 13 last year

Fri, 28-Oct-2016
Posted by: Biocon Biologics

Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45%; Revenues at Rs 992 Crs.; EBITDA at Rs 277 Crs.; Net Profit at Rs 147 Crs.

Thu, 20-Oct-2016
Posted by: Biocon Biologics

Biocon Appoints Suresh Subramanian as Head of Branded Formulations (India) Business

Mon, 19-Sep-2016
Posted by: Biocon Biologics

Kiran Mazumdar Shaw Appointed ‘Knight of the Legion of Honour’ by the Government of France

Thu, 01-Sep-2016
Posted by: Biocon Biologics

1
2